ATE367168T1 - Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon - Google Patents
Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferonInfo
- Publication number
- ATE367168T1 ATE367168T1 AT01920006T AT01920006T ATE367168T1 AT E367168 T1 ATE367168 T1 AT E367168T1 AT 01920006 T AT01920006 T AT 01920006T AT 01920006 T AT01920006 T AT 01920006T AT E367168 T1 ATE367168 T1 AT E367168T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- schaemia
- hypoxya
- interferon
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2001/000276 WO2002080959A1 (en) | 2001-04-03 | 2001-04-03 | Method of treatment of hypoxia/ischaemia blutflusswiderstand |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE367168T1 true ATE367168T1 (de) | 2007-08-15 |
Family
ID=19760746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01920006T ATE367168T1 (de) | 2001-04-03 | 2001-04-03 | Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon |
Country Status (6)
Country | Link |
---|---|
US (2) | US20040105843A1 (de) |
EP (2) | EP1372702B1 (de) |
AT (1) | ATE367168T1 (de) |
AU (1) | AU2002249692A1 (de) |
DE (1) | DE60129472T2 (de) |
WO (2) | WO2002080959A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005519946A (ja) * | 2002-03-12 | 2005-07-07 | マキシジェン エーピーエス | 発作の処置のためのインターフェロンβ様分子 |
AU2003273242A1 (en) * | 2002-08-27 | 2004-03-19 | Xavier Golay (Nmi) | Microvascular blood volume magnetic resonance imaging |
FI20030467A0 (fi) * | 2003-03-28 | 2003-03-28 | Sirpa Jalkanen | Menetelmä tulehdustilojen hoitamiseen |
PL1608400T3 (pl) * | 2003-03-28 | 2010-11-30 | Faron Pharmaceuticals Oy | Podwyższanie poziomu adenozyny przez indukowaną przez cytokiny ekspresję CD73 |
FI20051003A0 (fi) * | 2005-10-07 | 2005-10-07 | Faron Pharmaceuticals Oy | Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi |
EP2813144A1 (de) | 2006-10-09 | 2014-12-17 | Charleston Laboratories, Inc. | Analgetische Zusammensetzungen enthaltend ein Antihistamin |
EP2076533B1 (de) | 2007-05-02 | 2014-10-08 | Ambrx, Inc. | Modifizierte interferon-beta-polypeptide und ihre verwendungen |
ES2620672T3 (es) | 2008-01-09 | 2017-06-29 | Charleston Laboratories, Inc. | Comprimidos de doble capa que comprenden oxicodona y prometazina |
WO2011006012A1 (en) | 2009-07-08 | 2011-01-13 | Charleston Laboratories Inc. | Pharmaceutical compositions |
EP3423041A4 (de) | 2016-03-04 | 2019-09-11 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0797998A4 (de) * | 1995-11-17 | 2003-01-15 | Toray Industries | Schutz für endothelzellen |
JPH09151137A (ja) * | 1995-12-01 | 1997-06-10 | Toray Ind Inc | 平滑筋細胞増殖抑制剤 |
-
2001
- 2001-04-03 DE DE60129472T patent/DE60129472T2/de not_active Expired - Lifetime
- 2001-04-03 WO PCT/NL2001/000276 patent/WO2002080959A1/en active IP Right Grant
- 2001-04-03 AT AT01920006T patent/ATE367168T1/de not_active IP Right Cessation
- 2001-04-03 EP EP01920006A patent/EP1372702B1/de not_active Expired - Lifetime
-
2002
- 2002-04-03 AU AU2002249692A patent/AU2002249692A1/en not_active Abandoned
- 2002-04-03 EP EP02718708A patent/EP1377303A2/de not_active Withdrawn
- 2002-04-03 WO PCT/NL2002/000217 patent/WO2002080953A2/en not_active Application Discontinuation
-
2003
- 2003-10-01 US US10/676,847 patent/US20040105843A1/en not_active Abandoned
- 2003-10-03 US US10/678,957 patent/US20040136957A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040105843A1 (en) | 2004-06-03 |
AU2002249692A1 (en) | 2002-10-21 |
EP1372702B1 (de) | 2007-07-18 |
US20040136957A1 (en) | 2004-07-15 |
DE60129472T2 (de) | 2008-04-17 |
EP1372702A1 (de) | 2004-01-02 |
WO2002080959A1 (en) | 2002-10-17 |
WO2002080953A3 (en) | 2002-12-12 |
WO2002080953A2 (en) | 2002-10-17 |
DE60129472D1 (de) | 2007-08-30 |
EP1377303A2 (de) | 2004-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60129472D1 (de) | Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon | |
ES2187798T3 (es) | Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento. | |
DE60042736D1 (de) | Blutfilter zur behandlung von gefässerkrankungen | |
WO2006017470A3 (en) | Device and method for treating a vessel | |
WO2002060468A3 (en) | Antiviral activities of primate theta defensins and mammalian cathelicidins | |
EA200500646A1 (ru) | Фармацевтическая комбинация для лечения повреждений тканей, вызванных недостаточностью артериального кровотока | |
JPH07145076A (ja) | lys−プラスミノーゲンを含有する虚血性事象及び再灌流損傷の予防・治療剤 | |
RU2010153688A (ru) | Режим дозирования телапревира | |
Wigginton et al. | Advances in resuscitative trauma care | |
Chen et al. | Long-term follow-up study and comparison of meso-atrial shunts and meso-cavo-atrial shunts for treatment of combined Budd-Chiari syndrome | |
HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
EP1997503A3 (de) | Behandlung von Melanomen mit Alphathymosin-Peptiden | |
Blendis et al. | Stopping the unstoppable? | |
Obermaier et al. | Exogenous and endogenous nitric oxide donors improve post-ischemic tissue oxygenation in early pancreatic ischemia/reperfusion injury in the rat | |
ATE348628T1 (de) | Behandlung von hepatitis c mit thymosin, interferon und ribavirin | |
DE50015051D1 (de) | Mittel zum verschluss von blutgefässen | |
Ari | Chronic hepatitis C infection--eradication of the virus | |
RU2001115079A (ru) | Способ лечения секреторных форм мужского бесплодия | |
CN204318984U (zh) | 一种防止阴囊滑出的阴囊托带裤 | |
Antropova et al. | COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE | |
Nakata et al. | Surgical treatment of peripheral congenital vascular dysplasia | |
戴国华 et al. | Discussion on the TCM treatment of hypertension from pathogenetic viewpoints of modern medicine | |
RU98117264A (ru) | Способ инактивации вируса иммунодефицита человека и других вирусов в плазме крови человека с сохранением функциональной активности белков плазмы крови | |
Blaney | Experimental HIV drugs may improve prevention | |
Castedal et al. | Combination therapy of interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |